Leishmania (Leishmania) amazonensis Infection in Mice Treated With FTY720

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 578-581

  Lopes, C T ^a   de Paula, D M B ^a   Cury, P M ^b   Valero Lapchik, V B ^a   Bueno, V ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FINGOLIMOD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FOOT; INOCULATION; LEISHMANIA; LEISHMANIASIS; MEASUREMENT; MONOTHERAPY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; THICKNESS; TREATMENT DURATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HINDLIMB; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROPYLENE GLYCOLS; SPHINGOSINE; SPLEEN;

EID: 77949433499     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.01.026     Document Type: Article

References (13)

1. Barsoum R.S. Parasitic Infections in Organ Transplantation. Exp Clin Transplant 2 (2004) 258
2. Brinkmann V., Pinschewer D., Chiba K., et al. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 21 (2000) 49
3. Awasthi A., Mathur R.K., and Saha B. Immune response to Leishmania infection. Indian J Med Res 119 (2004) 238
4. Calabrese K.S., and Da Costa S.C. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine. Mem Inst Oswaldo Cruz 87 (1992) 49
5. Jones D.E., Ackermann M.R., Wille U., et al. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70 (2007) 2151
6. Silva E.M., Bertho A.L., and Mendonça S.C. Effect of in vivo depletion of CD4+ T cells on experimental infection of susceptible BALB/c mice with Leishmania amazonensis. Acta Trop 56 (1994) 111
7. Alves C.R., Benevolo-De-Andrade T.C., Alves J.L., et al. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis. Parasite Immunol 26 (2004) 127
8. Kursar M., Jnner N., Pfeffer K., et al. Requirement of secondary lymphoid tissues for the induction of primary and secondary T cell responses against Listeria monocytogenes. Eur J Immunol 38 (2008) 127
9. Pinschewer D.D., Ochsenbein A.F., Odermatt B., et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164 (2000) 5761
10. Tuon F.F., Amato V.S., Floeter-Winter L.M., et al. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids-first report. Int J Dermatol 46 (2007) 628
11. Castillo-Mendez S.I., Zago C.A., Sardinha L.R., et al. Characterization of the spleen B-cell compartment at the early and lat blood-stage Plasmodium chabaudi malaria. Scand J Immunol 66 (2007) 309
12. Wanasen N., Xin L., and Soong L. Pathogenic role of B cells and atibodies in murine Leishmania amazonensis infection. Int J Parasitol 38 (2008) 417
13. Hofmann M., Brinkmann V., and Zerwes H.G. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol 6 (2006) 1902